|
| Pronunciation |
 (hye
droe KOE done & klor fen IR a
meen) |
 |
| U.S. Brand Names |
| Tussionex® |
|
| Generic Available |
|
Yes |
|
| Synonyms |
| Chlorpheniramine and Hydrocodone |
|
| Pharmacological Index |
|
Antihistamine/Antitussive |
|
| Use |
|
Symptomatic relief of cough and allergy |
|
| Restrictions |
|
C-III |
|
| Pregnancy Risk Factor |
|
C |
|
| Adverse Reactions |
|
<1% (Limited to important or life-threatening symptoms): Drowsiness, sedation, lethargy, anxiety, facial pruritus, constipation, nausea, ureteral spasm, respiratory depression, dryness of pharynx |
|
| Pharmacodynamics/Kinetics |
|
Duration: Hydrocodone: 4-6 hours |
|
| Usual Dosage |
|
Oral: Adults: 5 mL every 12 hours; do not exceed 10 mL/24 hours |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
Prolonged use will cause significant xerostomia |
|
| Patient Information |
|
Pregnancy precautions: Inform prescriber if you are or intend to be pregnant. Do not breast-feed. |
|
| Nursing Implications |
|
Shake well before administering |
|
| Dosage Forms |
|
Syrup, alcohol free: Hydrocodone polistirex 10 mg and chlorpheniramine polistirex 8 mg per 5 mL (480 mL, 900 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
